5Zamperetti N, Ronco C, Brendolan A, et al. Bioethical issues related to continuous renal replacement therapy in intensive care patients [ J ]. Intensive care medicine, 2000,26 (4) : 407 -415.
6Tayebi Z, Borimnejad L, Dehghan-Nayeri N, et al. Rationales of restricted visiting hour in Iranian intensive care units: a qualitative study [ J ]. Nursing in critical care, 2014,19 (3) : 117-125.
6Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B. E.S.T. kidney) investigators. Intensive Care Med, 2007, 33: 1563-1570
7Shimizu T, Endo Y, Tsuchihashi H, et al. Endotoxin apheresis for sepsis. Transfus Apher Sci, 2006, 35: 271- 282.
8Ronco C, Cruz D, Bellomo R. Continuous renal replacement in critical illness. Contrib Nephrol, 2007, 156: 309-319.
9Cole L, Bellomo R, Davenport P, et al. Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion. Int J Artif Organs, 2004, 27: 388-397.
10Leone M, Boutiere-Albanese B, Valette S, et al. Ceil adhesion molecules as a marker reflecting the reduction of endothelial activation induced by glueocorticoids. Shock, 2004, 21: 311-314.
